elranatamab Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance NEW YORK–(BUSINESS WIRE) February 22, 2023 — Pfizer Inc. (NYSE:PFE) announced […]


vamorolone Treatment for Duchenne Muscular Dystrophy Santhera and ReveraGen Announce FDA Acceptance of New Drug Application for Vamorolone in Duchenne […]

Insights into Oncofertility

IntroductionThe needThe scopeEthical concernsPreserving fertility potentialContraception in cancer survivorsConclusionReferencesFurther Reading Introduction Oncofertility is a new term describing an area of […]